🐁 Mouse + 🧪 In vitro · 2025 · China (Hong Kong)
Wavelength-dependent photobiomodulation attenuates synovial inflammation in fibroblast-like synoviocytes and a collagenase-induced osteoarthritis model
Fan · J Photochem Photobiol B · 2025
The protocol this study used
What the authors concluded
While 940 nm PBM also demonstrated anti-inflammatory effects in vitro, it did not show significant efficacy in vivo. These findings suggest that PBM at 810 nm exerts stronger anti-inflammatory and chondroprotective effects in inflammatory OA compared with 940 nm, supporting its potential as a non-pharmacological intervention for inflammatory OA phenotypes." Note: A corrigendum was published at h
Devices that emit this wavelength
Matched on wavelength within 15nm, since LED bins vary by roughly that much and a tighter match would be false precision. Where we have an irradiance figure, the session length is the time needed to reach this study's dose of 39 J/cm² at that intensity.
DISCLOSURE — we earn commission on purchases made through our links, at no extra cost to you. Rankings come from specifications and measurements, never from commission rates.
Matching a wavelength is not the same as reproducing a trial. Session times assume the device's published irradiance is accurate at the distance it was measured, which on brand-claim figures is often optimistic. Where a device publishes both a peak and an average we use the average, and where it publishes a falloff curve we use the lowest figure, so these times run long rather than short. Clinical protocols also control for spot size, contact and skin type in ways a home device cannot.
Source
Dosimetry extracted by Vladimir Heiskanen in Photobiomodulation (PBM) research - a comprehensive database. Citation resolved against PubMed.